Compare PODD & ONTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PODD | ONTO |
|---|---|---|
| Founded | 2000 | 1940 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 9.4B |
| IPO Year | 2007 | 1995 |
| Metric | PODD | ONTO |
|---|---|---|
| Price | $144.22 | $334.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 8 |
| Target Price | ★ $341.48 | $290.63 |
| AVG Volume (30 Days) | ★ 1.3M | 1.1M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.30 | 0.67 |
| Revenue | ★ $2,708,100,000.00 | N/A |
| Revenue This Year | $24.55 | $26.63 |
| Revenue Next Year | $19.18 | $16.26 |
| P/E Ratio | ★ $111.97 | $499.72 |
| Revenue Growth | ★ 30.73 | N/A |
| 52 Week Low | $140.63 | $89.40 |
| 52 Week High | $354.88 | $348.76 |
| Indicator | PODD | ONTO |
|---|---|---|
| Relative Strength Index (RSI) | 39.29 | 65.62 |
| Support Level | $143.11 | $187.29 |
| Resistance Level | $161.35 | N/A |
| Average True Range (ATR) | 6.16 | 19.32 |
| MACD | 0.90 | 6.57 |
| Stochastic Oscillator | 14.97 | 85.54 |
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.